Results presented here showed platelet-rich plasma injection within 6 months of total shoulder arthroplasty may lead to an ...

Senior medical practitioners have outlined the potential benefits of a newly introduced Lenacapavir, a long-acting Human Immunodeficiency Virus prevention injection, saying it could significantly ...

Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two injections per year to one against HIV. "It is a hopeful step and the study data are ...

A drug currently used to treat HIV has also been found to dramatically reduce the risk of infection, significantly more than the primary option available for pre-exposure prophylaxis or PrEP. In a ...

Hepatitis B immunoglobulin (HBIG) injections can provide short-term protection against the hepatitis B virus. They may benefit people who have experienced recent exposure. Some people get acute ...

Nigerians are scrambling for Lenacapavir, a new anti-HIV injection for prevention. Learn about this twice-yearly PrEP drug ...

Nigeria has been selected as one of the early adopter countries for a new HIV prevention injection, following considerations ...